Longevity R&D
Translational research, not wellness marketing.
Our research is organised around a single discipline: can a claim about ageing be measured, tested and reproduced? Everything else follows from that.
Approach
Three commitments that shape every programme.
Longevity research has a credibility problem: too many claims, too little validation. Our approach is designed to be checkable.
Translational research
Questions framed so that an answer changes something: a biomarker, a dose, a safety limit, a clinical design.
Academic and clinical partnerships
We intend to work through established institutions rather than around them, with ethics review before data collection.
Data-driven validation
Pre-registered endpoints, reported whether or not the result is convenient. Negative findings are findings.
The biology of ageing
Four processes we are trying to understand.
Ageing is not one thing. These are the mechanisms most consistently implicated in decline — and the ones our programmes are built around.
Illustrative scientific imagery. Explanations are simplified for a general audience and are not medical advice.
Telomeres — the protective caps at the ends of chromosomes — shorten with each cell division. Once critically short, a cell can stop dividing or begin to malfunction. Telomere length is an appealing marker because it is measurable, but it is not destiny: long telomeres carry their own risks, and elongation alone has not been shown to produce healthy life extension.
What we are researching: how telomere dynamics interact with inflammation and tissue repair, rather than length as a single target.
AI and data platform
A platform built to hold decades of signal.
Longevity research only works if data can be followed over time. Our planned platform is designed around longitudinal depth, careful modelling, and privacy as an architectural constraint rather than a policy statement.
Longitudinal data
Consented, time-series measurement of the same people.
Predictive models
Uncertainty stated, not hidden behind a score.
Privacy-first
Minimised, encrypted, access-controlled by design.
Any future participant data would be handled under UK GDPR and, where applicable, CCPA — with explicit consent, purpose limitation and a stated retention period. No participant data is collected today.
Planned capability
Models narrow the search space. People, protocols and approvals decide what happens next.
Research collaboration
Have data, a cohort or a mechanism worth testing?
We are building a small number of research relationships with groups who share our standards for evidence.